Page 3,077«..1020..3,0763,0773,0783,079..3,0903,100..»

A Drug Might Heal Spinal Injuries By Sparking Nerve Growth

Posted: Published on December 4th, 2014

By increasing the amount of serotonin in the spinal cord, an experimental drug helps nerve connections work better. Bee Smith/Ocean/Corbis hide caption By increasing the amount of serotonin in the spinal cord, an experimental drug helps nerve connections work better. A scientist who chose to ignore the mainstream nearly 30 years ago has found a new way to regenerate nerves in the spinal cord, at least in animals. A drug that Jerry Silver, a professor of neuroscience at Case Western Reserve University, helped design a drug that has allowed paralyzed rats to regain bladder function and even walk. The drug works by releasing nerve fibers that have become trapped in scar tissue after a spinal cord injury, Silver says. "Now we've got something that might work in people," though it hasn't been tested in humans yet, he says. The study was published Wednesday in Nature. Everybody else in the world was asking why nerves grow where they do. And I thought I'd do something different and ask why they don't grow where they don't. - Jerry Silver The research that led to this drug began in the 1980s. At the time, Silver and many other scientists were studying nerves. "Everybody … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on A Drug Might Heal Spinal Injuries By Sparking Nerve Growth

Barrier-breaking drug may lead to spinal cord injury treatments

Posted: Published on December 4th, 2014

PUBLIC RELEASE DATE: 3-Dec-2014 Contact: Christopher Thomas thomaschr@ninds.nih.gov 301-496-5751 NIH/National Institute of Neurological Disorders and Stroke Injections of a new drug may partially relieve paralyzing spinal cord injuries, based on indications from a study in rats, which was partly funded by the National Institutes of Health The results demonstrate how fundamental laboratory research may lead to new therapies. "We're very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries," said Jerry Silver, Ph.D., professor of neurosciences, Case Western Reserve University School of Medicine, Cleveland, and a senior investigator of the study published in Nature. Every year, tens of thousands of people are paralyzed by spinal cord injuries. The injuries crush and sever the long axons of spinal cord nerve cells, blocking communication between the brain and the body and resulting in paralysis below the injury. On a hunch, Bradley Lang, Ph.D., the lead author of the study and a graduate student in Dr. Silver's lab, came up with the idea of designing a drug that would help axons regenerate without having to touch the healing spinal cord, as current treatments may require. "Originally this was just a side project we brainstormed … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Barrier-breaking drug may lead to spinal cord injury treatments

Test drug treats paralysis in rats

Posted: Published on December 4th, 2014

INQUIRER.net PHOTO PARIS, France A new compound, tested so far on rats, shows promise in restoring functions lost by paralyzing injury to the spinal cord, a study said on Wednesday. Called intracellular sigma peptide (ISP), the drug helped lab animals with severe spinal injury recover the ability to urinate or move, or both, it said. More work is needed, but the scientists behind ISP said the results boosted hopes for a future therapy for humans. Were very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries, said Jerry Silver, a professor of neurosciences at Case Western Reserve University in Cleveland, Ohio. Published in the journal Nature, the research looked at ways of overcoming scarring when nerve fibers in the spinal cord are damaged and signals from the brain no longer reach muscles below the injury site. Nerve fibers try to cross the injury site and reconnect with other fibers, but become trapped at the scar site by sticky proteins called proteoglycans. ISP is designed to act on the receptor on the surface of the nerve cells. Like a switch, it turns off a response to the proteoglycans that causes the blockage. … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Test drug treats paralysis in rats

'Unprecedented': Drug May Help Heal Damaged Spines

Posted: Published on December 4th, 2014

Researchers say they've developed a drug that may help heal a damaged spine the first time anything like a drug has been shown to help. The drug works on nerve cells that are cut, sending connections across the break, and it helped injured rats move their back legs again and also gave them back control of their bladders. "This recovery is unprecedented," said Jerry Silver, a neuroscience professor at Case Western Reserve University in Ohio who led the study. Right now, there's no good way to heal a broken spine. Sometimes people grow nerve cells back, but usually not. All the cures that are in the works require invasive surgery, whether it's injections of stem cells, nerve tissue transplants or implants of neurostimulators. But Silver's team came up with a compound that is injected. It doesn't require surgery. "We're very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries." "There are currently no drug therapies available that improve the very limited natural recovery from spinal cord injuries that patients experience," said Lyn Jakeman, a program director at the National Institute of Neurological Disorders and Stroke, part of the National Institutes of … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on 'Unprecedented': Drug May Help Heal Damaged Spines

Gismo Therapeutics Inc. Receives a Michael J. Fox Foundation for Parkinson's Research Grant

Posted: Published on December 4th, 2014

Lexington, Kentucky (PRWEB) December 03, 2014 Gismo Therapeutics Inc. is pleased to announce that it has been awarded a $235,000 Michael J. Fox Foundation for Parkinson's Research grant to investigate therapeutics directed against a newly identified disease pathway in Parkinsons disease. Gismo Therapeutics expertise is in small molecule compounds that target glycosaminoglycans, which have been identified as key molecules that promote the spread of neurodegenerative diseases into previously unaffected neurons. The grant was co-awarded to Patrik Brundin, M.D., Ph.D., the Jay Van Andel Endowed Chair in Parkinsons Research and Director of the Center for Neurodegenerative Science at Van Andel Research Institute (VARI) in Grand Rapids, Mich. The project, Targeting internalization and aggregation of alpha-synuclein proteopathic seeds with glycosaminoglycan interacting small molecules (GISMO): A novel therapeutic strategy for Parkinsons disease seeks to validate a little-explored disease pathway linked to the spread of Parkinson's disease. In this pathway, heparan sulfate glycosaminoglycan (HS-GAG) mediates internalization and aggregation of alpha-synuclein proteopathic seeds, which can lead to the clumps of misfolded alpha-synuclein protein that often are found in the brains of people with Parkinsons. Recent literature has linked these clumps of abnormal protein to the diseases spread. Discovering ways to interfere with this pathway have … Continue reading

Posted in Parkinson's Treatment | Comments Off on Gismo Therapeutics Inc. Receives a Michael J. Fox Foundation for Parkinson's Research Grant

Aldergrove attacker sought by police

Posted: Published on December 4th, 2014

Langley RCMP are hoping someone can identify this man, wanted for sucker punching a man and then kicking him in the head causing a brain injury at the Alder Inn parking lot on July 20. image credit: Langley RCMP submitted Langley RCMP are asking the publics help to identify a man who violently attacked another man, causing him to have a brain injury outside the Alder Inn on July 20. Shortly after midnight, the victim was walking in the Alder Inn parking lot in Aldergrove when he was attacked from behind with a punch to the head, said police. The victim lost consciousness and fell face first into the street. The suspect proceeded to kick the victim in the head before walking away. The victim was taken to hospital for treatment and was found to have a brain injury. Investigators have since obtained still photographs from nearby surveillance cameras. Anyone with information that may assist police can call 604-532-3200. Should you need to remain anonymous, call CrimeStoppers at 1-800-222-TIPS. See the article here: Aldergrove attacker sought by police … Continue reading

Posted in Brain Injury Treatment | Comments Off on Aldergrove attacker sought by police

First MS Patients in the U.S. Receive Genzymes Lemtrada Following FDA Approval

Posted: Published on December 4th, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company, today announced that the first U.S. patients have initiated treatment with Lemtrada (alemtuzumab) in the commercial setting following its November 14th FDA approval for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS. As an investigator in the Phase III clinical development program with firsthand experience, I have been awaiting the ability to prescribe Lemtrada to patients in my practice who could potentially benefit from this treatment, said Christopher LaGanke, M.D., founder of North Central Neurology Associates in Cullman, Ala. Following REMS training and certification, I am excited that I was able to become the first physician to initiate patient treatment in the United States. Lemtrada has a unique dosing and administration schedule of two annual treatment courses. The first treatment course is administered via intravenous infusion on five consecutive days, and the second course is administered on three consecutive days, 12 months later. The FDA approval of Lemtrada was based on two pivotal randomized Phase III open-label rater-blinded studies … Continue reading

Posted in MS Treatment | Comments Off on First MS Patients in the U.S. Receive Genzymes Lemtrada Following FDA Approval

Scientists, Nobel Laureates convene in SA for World Stem Cell Summit

Posted: Published on December 4th, 2014

NEWS Patients, their families also in attendance to remind scientists why their work matters Posted YESTERDAY, 5:28 PM Updated YESTERDAY, 5:30 PM SAN ANTONIO - Among the Nobel Laureates, scientists and fundraisers, some patients and their families are attending the 10th-Annual World Stem Cell Summit at the Marriott Rivercenter to remind the great minds what is at stake in their groundbreaking work. Roman Reed is wheeling around as fast as he can in his old, scratched and dirty wheelchair. Paralyzed in 1994 in a football accident, he was instrumental in getting "Romans Law" passed, which paved the way for stem cell research for paralysis patients. He said he is not buying another wheelchair because he feels he will not need it in the future. "We will have a cure. I will walk again, and so shall 5.6 million Americans," he said. Reed said even if you are not in a wheelchair and do not know anyone who is, you should still be concerned with the costs associated with people like himself, noting we spend $1.65 trillion a year in health care costs for paralyzed Americans. He won the Inspiration Award at last years World Stem Cell Summit, and continues to … Continue reading

Posted in Stem Cell Research | Comments Off on Scientists, Nobel Laureates convene in SA for World Stem Cell Summit

The Microbiome: A New Frontier in Human Health – Video

Posted: Published on December 4th, 2014

The Microbiome: A New Frontier in Human Health Traditionally the medical community has viewed microbes as the cause of illness and sought to eliminate them. This notion, however, is shifting as emerging research in the field of human microbiome... By: Center for Genetic Medicine … Continue reading

Comments Off on The Microbiome: A New Frontier in Human Health – Video

Kerala hospital develops new infertility cure

Posted: Published on December 3rd, 2014

(MENAFN - Khaleej Times) The new methodology called Endometrial Receptor Gene Assay (ERGA) developed by Craft Hospital and Research Centre, Kodungallur in Trichur district, helped 13 women majority of them with recurrent implantation failures to conceive successfully. The beneficiaries included a woman of Kerala origin with three successive IVF treatment failures in Australia. Her fourth conventional method of treatment at Craft also proved to be a failure. This prompted the Craft doctors to examine expressions of genes in the endometrine layer (inner layer) of her uterus. The examination revealed that the genes which help the embryo to remain in the uterus were very weak. The expressions of around 300 genes which are essential for conceiving a baby were observed through ERGA, a real time PCR technology developed by the Craft team. The IVF treatment conducted after giving medication to her to make these genes stronger became successful. She thus became the mother of the first child to have born through this treatment method in India. The new methodology also helped another Australian couple with 12 years of primary infertility and7 recurrent implantation failures to get a healthy baby. According to Craft Medical Director Prof. Dr. C. Mohamed Ashraf, ERGA is … Continue reading

Posted in IVF Treatment | Comments Off on Kerala hospital develops new infertility cure

Page 3,077«..1020..3,0763,0773,0783,079..3,0903,100..»